Cheddarific OP t1_is4bjnj wrote on October 13, 2022 at 5:08 AM

Reply to comment by marouane53 in Why do solid tumor oncology clinical trials commonly use transcriptomics instead of measuring specific protein biomarkers? by Cheddarific

I like this response. Your first point resonates with me, but on the second point: given the cost of clinical trials and the small number of patients in oncology trials in particular, is the cost difference really so extreme?